Actual Medicinal Product (AMP) Riluzole 50mg tablets (Viatris UK Healthcare Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products riluzole 50mg tablets (Glenmark Pharmaceuticals Europe Ltd) and riluzole 50mg tablets (Ranbaxy (UK) Limited).

Generic

Riluzole

Formulation

Riluzole 50mg tablets

Alternative Suppliers (21)

Rilutek 50mg tablets (Sanofi)

Riluzole 50mg tablets (Sigma Pharmaceuticals Plc)

Riluzole 50mg tablets (Sun Pharmaceutical Industries Europe B.V.)

Riluzole 50mg tablets (A A H Pharmaceuticals Ltd)

Riluzole 50mg tablets (Alliance Healthcare (Distribution) Ltd)

Riluzole 50mg tablets (DE Pharmaceuticals)

Rilutek 50mg tablets (Originalis B.V.)

Riluzole 50mg tablets (Torrent Pharma (UK) Ltd)

Riluzole 50mg tablets (Medihealth (Northern) Ltd)

Rilutek 50mg tablets (Waymade Healthcare Plc)

Rilutek 50mg tablets (DE Pharmaceuticals)

Rilutek 50mg tablets (Sigma Pharmaceuticals Plc)

Rilutek 50mg tablets (Necessity Supplies Ltd)

Riluzole 50mg tablets (Waymade Healthcare Plc)

Riluzole 50mg tablets (Teva UK Ltd)

Riluzole 50mg tablets (Viatris UK Healthcare Ltd)

Riluzole 50mg tablets (Sun Pharma UK Ltd)

Riluzole 50mg tablets (Accord-UK Ltd)

Riluzole 50mg tablets (Lupin Healthcare (UK) Ltd)

Riluzole 50mg tablets (Mawdsley-Brooks & Company Ltd)

Riluzole 50mg tablets (Pilsco Ltd)

Related Formulations (2)

Riluzole 50mg tablets

Riluzole 50mg orodispersible films